LOS ANGELES--(BUSINESS WIRE)--
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC ) investors concerning the Company and its officers’ possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to email@example.com , or visit our website at www.glancylaw.com .
Between March 13 and March 27, 2019, a series of reports alleged that the Company’s revenue base relied on “an exceedingly generous, but increasingly fragile, reimbursement regime.” These reports also alleged that the Company engaged in deceptive accounting practices.
On this news, shares of iRhythm fell $14.02 per share, or over 16%, over several trading sessions to close at $73.24 on March 28, 2019, thereby injuring investors.
If you purchased iRhythm securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9224, or visit our website at www.glancylaw.com . If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.